Raloxifene is used to prevent and treat osteoporosis (condition in which the bones become thin and weak and break easily) in postmenopausal (women who have experienced a change of life; end of menstrual periods) women. Raloxifene is also used to decrease the risk of developing invasive breast cancer (breast cancer that has spread outside of the milk ducts or lobules into the surrounding breast tissue) in postmenopausal women who are at high risk of developing this type of cancer or who have osteoporosis. Raloxifene cannot be used to treat invasive breast cancer or to prevent invasive breast cancer from coming back in women who have already had the condition. Raloxifene also cannot be used to decrease the risk of developing noninvasive breast cancer. Raloxifene should not be used in women who have not yet experienced menopause. Raloxifene is in a class of medications called selective estrogen receptor modulators (SERMs).

Filter

Showing all 5 results

  • Placeholder

    Denser tablet 60 mg 14’s

    Drugs affecting bone metabolism
    Rated 0 out of 5
     200.00
  • Placeholder

    Revera tablet 60 mg 2×7’s

    Drugs affecting bone metabolism
    Rated 0 out of 5
     200.00
  • Placeholder

    Relofin tablet 60 mg 14’s

    Drugs affecting bone metabolism
    Rated 0 out of 5
     200.00
  • Placeholder

    Osteonil tablet 60 mg 14’s

    Drugs affecting bone metabolism
    Rated 0 out of 5
     411.76
  • Placeholder

    Loxiam tablet 60 mg 2×7’s

    Drugs affecting bone metabolism
    Rated 0 out of 5
     200.00
Shopping Cart